We present a droplet-based microfluidic system that enables CRISPR-based gene editing and high-throughput screening on a chip. The microfluidic device contains a 10 × 10 element array, and each element contains sets of electrodes for two electric field-actuated operations: electrowetting for merging droplets to mix reagents and electroporation for transformation. This device can perform up to 100 genetic modification reactions in parallel, providing a scalable platform for generating the large number of engineered strains required for the combinatorial optimization of genetic pathways and predictable bioengineering. We demonstrate the system’s capabilities through the CRISPR-based engineering of two test cases: (1) disruption of the function of the enzyme galactokinase (galK) in E. coli and (2) targeted engineering of the glutamine synthetase gene (glnA) and the blue-pigment synthetase gene (bpsA) to improve indigoidine production in E. coli.
Optimizing enzymes to function in novel chemical environments is a central goal of synthetic biology, but optimization is often hindered by a rugged, expansive protein search space and costly experiments. In this work, we present TeleProt, an ML framework that blends evolutionary and experimental data to design diverse protein variant libraries, and employ it to improve the catalytic activity of a nuclease enzyme that degrades biofilms that accumulate on chronic wounds. After multiple rounds of high-throughput experiments using both TeleProt and standard directed evolution (DE) approaches in parallel, we find that our approach found a significantly better top-performing enzyme variant than DE, had a better hit rate at finding diverse, high-activity variants, and was even able to design a high-performance initial library using no prior experimental data. We have released a dataset of 55K nuclease variants, one of the most extensive genotype-phenotype enzyme activity landscapes to date, to drive further progress in ML-guided design.
We report the development of magnetically-driven, 100μm in typical diameter, core-shell microcapsules for the on-demand and local delivery of encapsulated drug agents. These microcapsules are fabricated through a multi-stage microfluidic/optofluidic flow-focusing device with oil-based core and thermoresponsive polymer shell. In the prototype capsules, the shell structure is constructed by UV-curable polyethylene glycol diacrylate (PEGDA) with embedded 20%w/w poly N-isopropylacrylamide (PNIPAm) nanogels and 0.5%w/w magnetic iron oxide nanoparticles (10 nm in diameter). Experimentally, the releases of the oil fluorescent dye from the core of the capsules have been successfully demonstrated by remotely triggering the capsules with induction heating. As such, this drug delivery scheme could be useful for remotely-triggered, site-specific applications.
We present a droplet-based microfluidic system that enables CRISPR-based gene editing and high-throughput screening on chip. The microfluidic device contains a 10 x 10 element array, each element containing sets of electrodes for two electric field actuated operations-electrowetting for merging droplets to mix reagents and electroporation for transformation. It can perform up to 100 genetic modifications in parallel, providing a scalable platform for generating the large number of engineered strains required for combinatorial optimization of genetic pathways and predictable bioengineering. We demonstrate the system’s capabilities through CRISPR-based engineering of two test cases-1) disruption of the function of enzyme galactokinase ( galK ) in E. coli and 2) targeted engineering of glutamine synthetase gene ( glnA ) and blue-pigment synthetase ( bpsA ) enzyme to improve indigoidine production in E. coli .